Endothelial Injury and Dysfunction with Emerging Immunotherapies in Multiple Myeloma, the Impact of COVID-19, and Endothelial Protection with a Focus on the Evolving Role of Defibrotide

Multiple myeloma and COVID-19, plus post-acute sequelae of SARS-CoV-2 infection, are associated with endothelial dysfunction and injury, with overlapping inflammatory pathways and coagulopathies.